Skip to content
  • Sunday, 26 July 2026
  • 2:49 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Salk Institute Identifies Med14 Protein as Key Regulator for GLP-1 Agonists’ Long-Term Pancreatic Health Benefits
Biotech & Genetic Research

Salk Institute Identifies Med14 Protein as Key Regulator for GLP-1 Agonists’ Long-Term Pancreatic Health Benefits

Jia Lissa Mar 25, 2026 0

Salk Institute researchers have pinpointed a crucial protein, Med14, that acts as a molecular bridge connecting GLP-1 agonist drugs to…

Read More
Clinical Diagnostics & Pathology

Doherty Institute Researchers Unveil Groundbreaking Assay for Rapid, Precise Detection of Four STIs and Antibiotic Resistance

Reynand Amr Wu Mar 25, 2026 0

Researchers at the Peter Doherty Institute for Infection and Immunity in Australia have developed a portable, point-of-care diagnostic tool capable…

Read More
Stem Cell & Regenerative Medicine

Salk Institute Researchers Identify BCL6 Protein as Key to Preventing Muscle Loss During GLP-1 Weight Management and Aging

Dwi Wanna Mar 22, 2026 0

The rise of glucagon-like peptide-1 (GLP-1) receptor agonists has fundamentally transformed the landscape of metabolic medicine, offering unprecedented efficacy in…

Read More

Posts pagination

1 2 3
Placebo Interventions Demonstrate Significant Cognitive and Physical Benefits for Older Adults Even When DisclosedSingaporean Scientists Unveil Revolutionary Spinach-Derived Photosynthetic Treatment for Chronic Dry Eye DiseaseA New Raptor Species, Kank australis, Unveiled in Patagonia, Reveals Ancient Fish-Hunting LifestyleBristol Myers Squibb Bets on Milvexian and Cobenfy to Drive Growth into the 2030s Amidst Patent Expiries
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ